LifeStance Health Group, Inc. (LFST)

LifeStance Health Group Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,585	1,424	1,251	1,056	859.54	667.51
Revenue Growth	20.38%	13.85%	18.50%	22.82%	28.77%	76.96%
Gross Profit Gross Profit Growth	531.85	461.1	402.4	302.1	237.02	201.51
Operating Income Operating Income Growth	80.45	25.17	-28.87	-121.61	-205.61	-283.76
Net Income Net Income Growth	50.6	9.66	-57.44	-186.26	-215.56	-343.95
Earnings Per Share EPS Growth	0.13	0.02	-0.15	-0.51	-0.61	-1.05
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Commercial Commercial Growth	1,410	1,281	1,138	960.13	776.34	601.85
Government Government Growth	96.91	76.14	57.88	44.65	37.06	29.44
Self-Pay Self-Pay Growth	67.5	56.19	43.88	40.8	36.38	28.92
Nonpatient Service Nonpatient Service Growth	10.39	10.63	11.29	10.09	9.76	7.31
Revenue (Total) Revenue (Total) Growth	1,585	1,424	1,251	1,056	859.54	667.51

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	225.94	248.64	154.57	78.82	108.62	148.03
Total Debt Total Debt Growth	474.15	474.52	485.19	511.04	478.83	158.74
Net Cash (Debt) Net Cash Growth	-248.21	-225.88	-330.62	-432.22	-370.21	-10.71
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.63	-0.58	-0.87	-1.18	-1.04	-0.03

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	217.87	146.15	107.26	-16.88	52.79	9.42
Capital Expenditures CapEx Growth	-43.96	-36.13	-21.57	-40.52	-79.26	-94.49
Free Cash Flow Free Cash Flow Growth	173.91	110.03	85.69	-57.4	-26.47	-85.07
Free Cash Flow Growth	44.84%	28.39%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	33.56%	32.37%	32.17%	28.62%	27.57%	30.19%
Operating Margin	5.08%	1.77%	-2.31%	-11.52%	-23.92%	-42.51%
Pretax Margin	4.23%	0.87%	-4.61%	-19.57%	-27.08%	-49.90%
Profit Margin	3.19%	0.68%	-4.59%	-17.64%	-25.08%	-51.53%
FCF Margin	10.97%	7.72%	6.85%	-5.44%	-3.08%	-12.75%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	92.44	283.41	-	-	-	-
Forward PE	64.38	228.57	278.81	278.81	278.81	278.81
P/FCF Ratio	26.17	24.89	32.91	-	-	-
PS Ratio	2.87	1.92	2.25	2.81	2.16	5.34

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Oct 1, 2026

Data Sources Report a data error